25 XP   0   0   10

Bloomage Biotechnology Corp Ltd
Buy, Hold or Sell?

Let's analyse Bloomage Biotechnology Corp Ltd together

PenkeI guess you are interested in Bloomage Biotechnology Corp Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bloomage Biotechnology Corp Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bloomage Biotechnology Corp Ltd

I send you an email if I find something interesting about Bloomage Biotechnology Corp Ltd.

Quick analysis of Bloomage Biotechnology Corp Ltd (30 sec.)










What can you expect buying and holding a share of Bloomage Biotechnology Corp Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.09
When do you have the money?
1 year
How often do you get paid?
78.9%

What is your share worth?

Current worth
¥14.48
Expected worth in 1 year
¥15.89
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥2.05
Return On Investment
3.6%

For what price can you sell your share?

Current Price per Share
¥56.17
Expected price per share
¥50.22 - ¥63.98
How sure are you?
50%

1. Valuation of Bloomage Biotechnology Corp Ltd (5 min.)




Live pricePrice per Share (EOD)

¥56.17

Intrinsic Value Per Share

¥2.93 - ¥3.55

Total Value Per Share

¥17.41 - ¥18.03

2. Growth of Bloomage Biotechnology Corp Ltd (5 min.)




Is Bloomage Biotechnology Corp Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$965.2m$833m$118.6m12.5%

How much money is Bloomage Biotechnology Corp Ltd making?

Current yearPrevious yearGrowGrow %
Making money$27.9m$31.2m-$3.3m-12.0%
Net Profit Margin12.6%14.7%--

How much money comes from the company's main activities?

3. Financial Health of Bloomage Biotechnology Corp Ltd (5 min.)




4. Comparing to competitors in the Specialty Chemicals industry (5 min.)




  Industry Rankings (Specialty Chemicals)  


Richest
#123 / 565

Most Revenue
#171 / 565

Most Profit
#103 / 565

What can you expect buying and holding a share of Bloomage Biotechnology Corp Ltd? (5 min.)

Welcome investor! Bloomage Biotechnology Corp Ltd's management wants to use your money to grow the business. In return you get a share of Bloomage Biotechnology Corp Ltd.

What can you expect buying and holding a share of Bloomage Biotechnology Corp Ltd?

First you should know what it really means to hold a share of Bloomage Biotechnology Corp Ltd. And how you can make/lose money.

Speculation

The Price per Share of Bloomage Biotechnology Corp Ltd is ¥56.17. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bloomage Biotechnology Corp Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bloomage Biotechnology Corp Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥14.48. Based on the TTM, the Book Value Change Per Share is ¥0.35 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.16 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bloomage Biotechnology Corp Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.0%0.060.1%0.060.1%0.050.1%0.050.1%
Usd Book Value Change Per Share0.020.0%0.050.1%0.060.1%0.110.2%0.110.2%
Usd Dividend Per Share0.000.0%0.020.0%0.020.0%0.020.0%0.020.0%
Usd Total Gains Per Share0.020.0%0.070.1%0.080.1%0.120.2%0.120.2%
Usd Price Per Share12.00-14.69-19.01-15.88-15.88-
Price to Earnings Ratio116.33-72.00-73.79-74.54-74.54-
Price-to-Total Gains Ratio570.63-277.91-249.85-376.59-376.59-
Price to Book Ratio5.99-7.46-11.03-9.99-9.99-
Price-to-Total Gains Ratio570.63-277.91-249.85-376.59-376.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.773928
Number of shares128
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.050.11
Usd Total Gains Per Share0.070.12
Gains per Quarter (128 shares)9.0715.99
Gains per Year (128 shares)36.2763.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1112526105454
223506220108118
334759830162182
44510013440216246
55612517050270310
66815020660324374
77917524270378438
89020027880432502
910122531490486566
10113250350100540630

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%11.01.00.091.7%17.02.00.089.5%17.02.00.089.5%17.02.00.089.5%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%15.00.04.078.9%15.00.04.078.9%15.00.04.078.9%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%

Fundamentals of Bloomage Biotechnology Corp Ltd

About Bloomage Biotechnology Corp Ltd

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is headquartered in Jinan, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-03-28 04:11:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Bloomage Biotechnology Corp Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bloomage Biotechnology Corp Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Bloomage Biotechnology Corp Ltd to the Specialty Chemicals industry mean.
  • A Net Profit Margin of 7.8% means that ¥0.08 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bloomage Biotechnology Corp Ltd:

  • The MRQ is 7.8%. The company is making a profit. +1
  • The TTM is 12.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ7.8%TTM12.6%-4.7%
TTM12.6%YOY14.7%-2.1%
TTM12.6%5Y20.7%-8.1%
5Y20.7%10Y20.7%0.0%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ7.8%4.2%+3.6%
TTM12.6%4.2%+8.4%
YOY14.7%6.4%+8.3%
5Y20.7%6.0%+14.7%
10Y20.7%6.0%+14.7%
1.1.2. Return on Assets

Shows how efficient Bloomage Biotechnology Corp Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bloomage Biotechnology Corp Ltd to the Specialty Chemicals industry mean.
  • 1.1% Return on Assets means that Bloomage Biotechnology Corp Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bloomage Biotechnology Corp Ltd:

  • The MRQ is 1.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.1%TTM2.4%-1.3%
TTM2.4%YOY2.9%-0.6%
TTM2.4%5Y3.3%-0.9%
5Y3.3%10Y3.3%0.0%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1%1.1%0.0%
TTM2.4%1.1%+1.3%
YOY2.9%1.7%+1.2%
5Y3.3%1.6%+1.7%
10Y3.3%1.7%+1.6%
1.1.3. Return on Equity

Shows how efficient Bloomage Biotechnology Corp Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bloomage Biotechnology Corp Ltd to the Specialty Chemicals industry mean.
  • 1.3% Return on Equity means Bloomage Biotechnology Corp Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bloomage Biotechnology Corp Ltd:

  • The MRQ is 1.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.3%TTM3.0%-1.7%
TTM3.0%YOY3.8%-0.8%
TTM3.0%5Y4.0%-1.0%
5Y4.0%10Y4.0%0.0%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%2.2%-0.9%
TTM3.0%2.0%+1.0%
YOY3.8%3.2%+0.6%
5Y4.0%2.7%+1.3%
10Y4.0%2.8%+1.2%

1.2. Operating Efficiency of Bloomage Biotechnology Corp Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bloomage Biotechnology Corp Ltd is operating .

  • Measures how much profit Bloomage Biotechnology Corp Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bloomage Biotechnology Corp Ltd to the Specialty Chemicals industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bloomage Biotechnology Corp Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM11.4%-11.4%
TTM11.4%YOY15.4%-3.9%
TTM11.4%5Y22.7%-11.3%
5Y22.7%10Y22.7%0.0%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.5%-7.5%
TTM11.4%4.8%+6.6%
YOY15.4%8.2%+7.2%
5Y22.7%8.1%+14.6%
10Y22.7%7.3%+15.4%
1.2.2. Operating Ratio

Measures how efficient Bloomage Biotechnology Corp Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • An Operation Ratio of 1.21 means that the operating costs are ¥1.21 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Bloomage Biotechnology Corp Ltd:

  • The MRQ is 1.205. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.119. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.205TTM1.119+0.087
TTM1.119YOY1.051+0.068
TTM1.1195Y0.979+0.139
5Y0.97910Y0.9790.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2051.529-0.324
TTM1.1191.530-0.411
YOY1.0511.459-0.408
5Y0.9791.462-0.483
10Y0.9791.229-0.250

1.3. Liquidity of Bloomage Biotechnology Corp Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bloomage Biotechnology Corp Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Current Ratio of 2.89 means the company has ¥2.89 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Bloomage Biotechnology Corp Ltd:

  • The MRQ is 2.891. The company is able to pay all its short-term debts. +1
  • The TTM is 2.707. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.891TTM2.707+0.183
TTM2.707YOY2.973-0.266
TTM2.7075Y5.257-2.550
5Y5.25710Y5.2570.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8911.831+1.060
TTM2.7071.875+0.832
YOY2.9731.896+1.077
5Y5.2571.926+3.331
10Y5.2571.762+3.495
1.3.2. Quick Ratio

Measures if Bloomage Biotechnology Corp Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bloomage Biotechnology Corp Ltd to the Specialty Chemicals industry mean.
  • A Quick Ratio of 0.53 means the company can pay off ¥0.53 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bloomage Biotechnology Corp Ltd:

  • The MRQ is 0.533. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.564. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.533TTM0.564-0.032
TTM0.564YOY0.837-0.273
TTM0.5645Y1.269-0.705
5Y1.26910Y1.2690.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5330.846-0.313
TTM0.5640.884-0.320
YOY0.8370.966-0.129
5Y1.2691.049+0.220
10Y1.2691.030+0.239

1.4. Solvency of Bloomage Biotechnology Corp Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bloomage Biotechnology Corp Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bloomage Biotechnology Corp Ltd to Specialty Chemicals industry mean.
  • A Debt to Asset Ratio of 0.16 means that Bloomage Biotechnology Corp Ltd assets are financed with 16.5% credit (debt) and the remaining percentage (100% - 16.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bloomage Biotechnology Corp Ltd:

  • The MRQ is 0.165. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.187. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.165TTM0.187-0.023
TTM0.187YOY0.215-0.027
TTM0.1875Y0.162+0.026
5Y0.16210Y0.1620.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1650.431-0.266
TTM0.1870.427-0.240
YOY0.2150.426-0.211
5Y0.1620.433-0.271
10Y0.1620.439-0.277
1.4.2. Debt to Equity Ratio

Measures if Bloomage Biotechnology Corp Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bloomage Biotechnology Corp Ltd to the Specialty Chemicals industry mean.
  • A Debt to Equity ratio of 19.9% means that company has ¥0.20 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bloomage Biotechnology Corp Ltd:

  • The MRQ is 0.199. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.233. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.199TTM0.233-0.035
TTM0.233YOY0.274-0.041
TTM0.2335Y0.197+0.037
5Y0.19710Y0.1970.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1990.767-0.568
TTM0.2330.752-0.519
YOY0.2740.747-0.473
5Y0.1970.797-0.600
10Y0.1970.845-0.648

2. Market Valuation of Bloomage Biotechnology Corp Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Bloomage Biotechnology Corp Ltd generates.

  • Above 15 is considered overpriced but always compare Bloomage Biotechnology Corp Ltd to the Specialty Chemicals industry mean.
  • A PE ratio of 116.33 means the investor is paying ¥116.33 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bloomage Biotechnology Corp Ltd:

  • The EOD is 75.329. Based on the earnings, the company is expensive. -2
  • The MRQ is 116.326. Based on the earnings, the company is expensive. -2
  • The TTM is 72.001. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD75.329MRQ116.326-40.997
MRQ116.326TTM72.001+44.325
TTM72.001YOY73.791-1.790
TTM72.0015Y74.536-2.535
5Y74.53610Y74.5360.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD75.32915.013+60.316
MRQ116.32613.988+102.338
TTM72.00115.705+56.296
YOY73.79117.841+55.950
5Y74.53619.498+55.038
10Y74.53623.950+50.586
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bloomage Biotechnology Corp Ltd:

  • The EOD is -47.105. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -72.742. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 9.304. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-47.105MRQ-72.742+25.637
MRQ-72.742TTM9.304-82.046
TTM9.304YOY-0.150+9.454
TTM9.3045Y122.483-113.178
5Y122.48310Y122.4830.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD-47.1055.077-52.182
MRQ-72.7424.568-77.310
TTM9.3042.302+7.002
YOY-0.150-0.150+0.000
5Y122.4833.140+119.343
10Y122.4832.653+119.830
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bloomage Biotechnology Corp Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A PB ratio of 5.99 means the investor is paying ¥5.99 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Bloomage Biotechnology Corp Ltd:

  • The EOD is 3.879. Based on the equity, the company is fair priced.
  • The MRQ is 5.991. Based on the equity, the company is overpriced. -1
  • The TTM is 7.457. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.879MRQ5.991-2.111
MRQ5.991TTM7.457-1.466
TTM7.457YOY11.031-3.574
TTM7.4575Y9.988-2.531
5Y9.98810Y9.9880.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD3.8791.713+2.166
MRQ5.9911.781+4.210
TTM7.4571.854+5.603
YOY11.0312.306+8.725
5Y9.9882.351+7.637
10Y9.9882.842+7.146
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Bloomage Biotechnology Corp Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1370.353-61%0.435-69%0.762-82%0.762-82%
Book Value Per Share--14.47914.276+1%12.496+16%10.607+37%10.607+37%
Current Ratio--2.8912.707+7%2.973-3%5.257-45%5.257-45%
Debt To Asset Ratio--0.1650.187-12%0.215-23%0.162+2%0.162+2%
Debt To Equity Ratio--0.1990.233-15%0.274-28%0.197+1%0.197+1%
Dividend Per Share--0.0150.159-90%0.126-88%0.141-89%0.141-89%
Eps--0.1860.419-55%0.469-60%0.382-51%0.382-51%
Free Cash Flow Per Share---0.298-0.100-67%0.082-462%-0.024-92%-0.024-92%
Free Cash Flow To Equity Per Share---0.298-0.307+3%-0.006-98%-0.096-68%-0.096-68%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.553--------
Intrinsic Value_10Y_min--2.932--------
Intrinsic Value_1Y_max--0.014--------
Intrinsic Value_1Y_min--0.013--------
Intrinsic Value_3Y_max--0.302--------
Intrinsic Value_3Y_min--0.283--------
Intrinsic Value_5Y_max--0.905--------
Intrinsic Value_5Y_min--0.818--------
Market Cap27055854158.720-54%41780770711.08051127722946.670-18%66166904862.880-37%55260892750.002-24%55260892750.002-24%
Net Profit Margin--0.0780.126-38%0.147-47%0.207-62%0.207-62%
Operating Margin---0.114-100%0.154-100%0.227-100%0.227-100%
Operating Ratio--1.2051.119+8%1.051+15%0.979+23%0.979+23%
Pb Ratio3.879-54%5.9917.457-20%11.031-46%9.988-40%9.988-40%
Pe Ratio75.329-54%116.32672.001+62%73.791+58%74.536+56%74.536+56%
Price Per Share56.170-54%86.740106.145-18%137.368-37%114.726-24%114.726-24%
Price To Free Cash Flow Ratio-47.105+35%-72.7429.304-882%-0.150-100%122.483-159%122.483-159%
Price To Total Gains Ratio369.521-54%570.630277.909+105%249.847+128%376.595+52%376.595+52%
Quick Ratio--0.5330.564-6%0.837-36%1.269-58%1.269-58%
Return On Assets--0.0110.024-55%0.029-64%0.033-68%0.033-68%
Return On Equity--0.0130.030-56%0.038-66%0.040-67%0.040-67%
Total Gains Per Share--0.1520.512-70%0.561-73%0.903-83%0.903-83%
Usd Book Value--965226735.375951673738.429+1%833038201.166+16%707107285.205+37%707107285.205+37%
Usd Book Value Change Per Share--0.0190.049-61%0.060-69%0.105-82%0.105-82%
Usd Book Value Per Share--2.0041.976+1%1.729+16%1.468+37%1.468+37%
Usd Dividend Per Share--0.0020.022-90%0.017-88%0.019-89%0.019-89%
Usd Eps--0.0260.058-55%0.065-60%0.053-51%0.053-51%
Usd Free Cash Flow---19873201.888-6649828.935-67%5488142.812-462%-1537530.685-92%-1537530.685-92%
Usd Free Cash Flow Per Share---0.041-0.014-67%0.011-462%-0.003-92%-0.003-92%
Usd Free Cash Flow To Equity Per Share---0.041-0.042+3%-0.001-98%-0.013-68%-0.013-68%
Usd Market Cap3744530215.567-54%5782458666.4137076076855.819-18%9157499633.023-37%7648107556.600-24%7648107556.600-24%
Usd Price Per Share7.774-54%12.00514.690-18%19.012-37%15.878-24%15.878-24%
Usd Profit--12427237.42727952629.662-56%31294746.997-60%25488193.280-51%25488193.280-51%
Usd Revenue--158581949.063216604780.337-27%216454614.230-27%146024422.272+9%146024422.272+9%
Usd Total Gains Per Share--0.0210.071-70%0.078-73%0.125-83%0.125-83%
 EOD+3 -5MRQTTM+12 -23YOY+9 -265Y+8 -2710Y+8 -27

3.2. Fundamental Score

Let's check the fundamental score of Bloomage Biotechnology Corp Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1575.329
Price to Book Ratio (EOD)Between0-13.879
Net Profit Margin (MRQ)Greater than00.078
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.533
Current Ratio (MRQ)Greater than12.891
Debt to Asset Ratio (MRQ)Less than10.165
Debt to Equity Ratio (MRQ)Less than10.199
Return on Equity (MRQ)Greater than0.150.013
Return on Assets (MRQ)Greater than0.050.011
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Bloomage Biotechnology Corp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.913
Ma 20Greater thanMa 5060.356
Ma 50Greater thanMa 10061.536
Ma 100Greater thanMa 20065.792
OpenGreater thanClose55.990
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Interest Expense  3987,8348,231-6,6221,6092,7444,353-5,189-836
Interest Income  8,64357,65866,301-55,27511,027-70610,320-61,264-50,944



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets8,349,564
Total Liabilities1,375,382
Total Stockholder Equity6,926,287
 As reported
Total Liabilities 1,375,382
Total Stockholder Equity+ 6,926,287
Total Assets = 8,349,564

Assets

Total Assets8,349,564
Total Current Assets3,207,373
Long-term Assets5,142,190
Total Current Assets
Cash And Cash Equivalents 1,127,092
Short-term Investments 70,236
Net Receivables 520,716
Inventory 1,197,535
Other Current Assets 41,897
Total Current Assets  (as reported)3,207,373
Total Current Assets  (calculated)2,957,476
+/- 249,897
Long-term Assets
Property Plant Equipment 3,318,525
Goodwill 248,726
Intangible Assets 486,823
Long-term Assets Other 379,878
Long-term Assets  (as reported)5,142,190
Long-term Assets  (calculated)4,433,951
+/- 708,239

Liabilities & Shareholders' Equity

Total Current Liabilities1,109,577
Long-term Liabilities265,805
Total Stockholder Equity6,926,287
Total Current Liabilities
Short Long Term Debt 134,638
Accounts payable 583,218
Other Current Liabilities 5,367
Total Current Liabilities  (as reported)1,109,577
Total Current Liabilities  (calculated)723,222
+/- 386,354
Long-term Liabilities
Long term Debt 2,614
Capital Lease Obligations Min Short Term Debt61,549
Long-term Liabilities  (as reported)265,805
Long-term Liabilities  (calculated)64,164
+/- 201,642
Total Stockholder Equity
Retained Earnings 2,369,553
Total Stockholder Equity (as reported)6,926,287
Total Stockholder Equity (calculated)2,369,553
+/- 4,556,735
Other
Capital Stock481,678
Common Stock Shares Outstanding 481,678
Net Invested Capital 7,063,539
Net Working Capital 2,097,797
Property Plant and Equipment Gross 3,318,525



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
> Total Assets 
0
2,097,557
2,349,865
2,500,889
4,971,660
5,031,639
5,339,838
5,307,335
5,716,894
6,052,084
6,548,316
6,649,969
7,503,740
7,414,325
7,831,545
7,906,332
8,681,754
8,459,570
8,368,322
8,349,564
8,349,5648,368,3228,459,5708,681,7547,906,3327,831,5457,414,3257,503,7406,649,9696,548,3166,052,0845,716,8945,307,3355,339,8385,031,6394,971,6602,500,8892,349,8652,097,5570
   > Total Current Assets 
0
1,239,745
1,278,761
1,405,248
3,770,683
3,723,670
3,918,373
3,654,312
3,663,574
3,611,908
3,800,562
3,756,818
3,984,153
3,564,656
3,836,372
3,670,450
4,023,100
3,546,741
3,314,356
3,207,373
3,207,3733,314,3563,546,7414,023,1003,670,4503,836,3723,564,6563,984,1533,756,8183,800,5623,611,9083,663,5743,654,3123,918,3733,723,6703,770,6831,405,2481,278,7611,239,7450
       Cash And Cash Equivalents 
0
737,399
720,053
704,967
2,201,461
1,378,308
1,575,892
1,279,979
1,390,314
1,302,782
1,715,910
1,262,650
1,806,636
1,794,439
1,752,354
1,029,197
1,606,129
1,388,473
1,276,628
1,127,092
1,127,0921,276,6281,388,4731,606,1291,029,1971,752,3541,794,4391,806,6361,262,6501,715,9101,302,7821,390,3141,279,9791,575,8921,378,3082,201,461704,967720,053737,3990
       Short-term Investments 
0
3,000
0
0
0
613,000
784,275
623,522
722,697
805,692
220,917
519,376
846,894
322,012
528,461
851,219
530,723
200,149
70,261
70,236
70,23670,261200,149530,723851,219528,461322,012846,894519,376220,917805,692722,697623,522784,275613,0000003,0000
       Net Receivables 
0
216,687
221,146
332,036
400,936
382,566
329,839
385,469
423,686
435,081
398,972
386,661
431,117
403,041
424,388
497,816
448,437
542,021
598,796
520,716
520,716598,796542,021448,437497,816424,388403,041431,117386,661398,972435,081423,686385,469329,839382,566400,936332,036221,146216,6870
       Other Current Assets 
0
7,026
17,908
21,897
52,326
1,003,847
84,148
951,085
70,882
493,730
96,279
924,162
190,373
234,256
173,289
214,689
43,167
237,295
193,566
41,897
41,897193,566237,29543,167214,689173,289234,256190,373924,16296,279493,73070,882951,08584,1481,003,84752,32621,89717,9087,0260
   > Long-term Assets 
0
857,812
1,071,104
1,095,642
1,200,977
1,307,969
1,421,465
1,653,023
2,053,320
2,440,175
2,747,754
2,893,152
3,519,588
3,849,669
3,995,173
4,235,882
4,658,654
4,912,829
5,053,966
5,142,190
5,142,1905,053,9664,912,8294,658,6544,235,8823,995,1733,849,6693,519,5882,893,1522,747,7542,440,1752,053,3201,653,0231,421,4651,307,9691,200,9771,095,6421,071,104857,8120
       Property Plant Equipment 
492,641
474,101
516,999
0
658,300
720,103
817,103
983,925
1,258,079
1,448,125
1,941,036
2,005,155
2,305,455
2,394,827
2,562,354
2,608,974
2,828,431
3,008,275
3,193,794
3,318,525
3,318,5253,193,7943,008,2752,828,4312,608,9742,562,3542,394,8272,305,4552,005,1551,941,0361,448,1251,258,079983,925817,103720,103658,3000516,999474,101492,641
       Goodwill 
0
70,323
72,707
72,119
72,693
72,631
73,757
77,090
74,641
73,217
71,490
69,988
67,151
65,896
65,186
65,007
247,219
247,885
251,443
248,726
248,726251,443247,885247,21965,00765,18665,89667,15169,98871,49073,21774,64177,09073,75772,63172,69372,11972,70770,3230
       Intangible Assets 
0
162,132
389,530
387,164
385,482
395,116
393,306
424,666
426,738
441,531
478,785
473,807
467,261
464,690
457,924
453,896
475,063
470,981
487,704
486,823
486,823487,704470,981475,063453,896457,924464,690467,261473,807478,785441,531426,738424,666393,306395,116385,482387,164389,530162,1320
       Long-term Assets Other 
0
102,904
43,198
41,198
54,540
14,409
82,907
1,043,662
180,637
321,698
93,741
94,868
445,457
605,382
649,091
674,970
558,557
619,342
442,312
379,878
379,878442,312619,342558,557674,970649,091605,382445,45794,86893,741321,698180,6371,043,66282,90714,40954,54041,19843,198102,9040
> Total Liabilities 
0
277,198
367,054
362,214
422,106
375,453
697,434
492,276
698,758
876,111
1,311,427
1,193,309
1,801,280
1,402,519
1,763,493
1,612,402
1,998,766
1,520,133
1,459,907
1,375,382
1,375,3821,459,9071,520,1331,998,7661,612,4021,763,4931,402,5191,801,2801,193,3091,311,427876,111698,758492,276697,434375,453422,106362,214367,054277,1980
   > Total Current Liabilities 
0
237,029
324,524
321,194
365,696
282,720
548,357
345,268
552,870
508,514
938,791
811,747
1,400,507
1,035,833
1,412,909
1,269,477
1,644,039
1,282,696
1,215,612
1,109,577
1,109,5771,215,6121,282,6961,644,0391,269,4771,412,9091,035,8331,400,507811,747938,791508,514552,870345,268548,357282,720365,696321,194324,524237,0290
       Short-term Debt 
0
40,000
40,000
40,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000040,00040,00040,0000
       Short Long Term Debt 
0
40,000
40,000
40,000
0
0
23,879
23,982
24,075
41,688
74,935
71,946
86,064
89,946
235,066
245,721
229,399
299,495
147,164
134,638
134,638147,164299,495229,399245,721235,06689,94686,06471,94674,93541,68824,07523,98223,8790040,00040,00040,0000
       Accounts payable 
0
44,121
89,852
78,809
53,307
69,815
58,883
80,847
119,077
166,442
115,791
220,500
243,546
539,500
252,554
506,552
848,339
608,648
650,990
583,218
583,218650,990608,648848,339506,552252,554539,500243,546220,500115,791166,442119,07780,84758,88369,81553,30778,80989,85244,1210
       Other Current Liabilities 
0
0
105,358
0
108,128
120,650
288,546
172,509
173,076
235,134
440,323
336,763
366,809
311,065
329,552
247,219
7,839
189,805
203,751
5,367
5,367203,751189,8057,839247,219329,552311,065366,809336,763440,323235,134173,076172,509288,546120,650108,1280105,35800
   > Long-term Liabilities 
0
40,169
42,530
41,019
56,410
92,734
149,076
147,008
145,888
367,598
372,635
381,562
400,773
366,686
350,584
342,925
354,728
237,437
244,295
265,805
265,805244,295237,437354,728342,925350,584366,686400,773381,562372,635367,598145,888147,008149,07692,73456,41041,01942,53040,1690
       Capital Lease Obligations Min Short Term Debt
0
-40,000
-40,000
-40,000
0
0
0
0
0
43,015
64,447
69,358
69,770
73,903
50,218
43,402
52,423
38,251
46,221
61,549
61,54946,22138,25152,42343,40250,21873,90369,77069,35864,44743,01500000-40,000-40,000-40,0000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000
       Deferred Long Term Liability 
6,165
11,759
11,209
0
18,907
17,746
17,699
16,844
15,642
15,606
17,572
22,944
31,847
32,732
33,200
61,993
0
113,473
109,450
0
0109,450113,473061,99333,20032,73231,84722,94417,57215,60615,64216,84417,69917,74618,907011,20911,7596,165
> Total Stockholder Equity
0
1,820,414
1,983,069
2,139,204
4,550,342
4,657,189
4,643,636
4,816,413
5,019,757
5,174,918
5,233,934
5,451,216
5,699,012
6,012,630
6,071,204
6,298,139
6,633,776
6,883,738
6,856,249
6,926,287
6,926,2876,856,2496,883,7386,633,7766,298,1396,071,2046,012,6305,699,0125,451,2165,233,9345,174,9185,019,7574,816,4134,643,6364,657,1894,550,3422,139,2041,983,0691,820,4140
   Common Stock
430,437
430,437
430,437
0
480,000
480,000
480,000
480,000
480,000
480,000
480,000
480,000
480,000
481,085
481,085
481,085
0
481,524
481,678
0
0481,678481,5240481,085481,085481,085480,000480,000480,000480,000480,000480,000480,000480,000480,0000430,437430,437430,437
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
409
-3,632
1,182
0
-1,187
-2,386
2,649
4,918
-12
-5,362
-8,406
-13,090
-23,907
-28,594
-30,672
-32,308
0
-9,708
11,239
0
011,239-9,7080-32,308-30,672-28,594-23,907-13,090-8,406-5,362-124,9182,649-2,386-1,18701,182-3,632409



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue6,359,192
Cost of Revenue-1,463,227
Gross Profit4,895,9654,895,965
 
Operating Income (+$)
Gross Profit4,895,965
Operating Expense-5,248,661
Operating Income1,110,531-352,696
 
Operating Expense (+$)
Research Development388,188
Selling General Administrative3,177,215
Selling And Marketing Expenses0
Operating Expense5,248,6613,565,403
 
Net Interest Income (+$)
Interest Income38,528
Interest Expense-14,523
Other Finance Cost-535
Net Interest Income23,471
 
Pretax Income (+$)
Operating Income1,110,531
Net Interest Income23,471
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,136,1121,110,531
EBIT - interestExpense = 1,124,190
1,139,316
985,442
Interest Expense14,523
Earnings Before Interest and Taxes (EBIT)1,138,7131,150,635
Earnings Before Interest and Taxes (EBITDA)1,364,246
 
After tax Income (+$)
Income Before Tax1,136,112
Tax Provision-174,732
Net Income From Continuing Ops961,380961,380
Net Income970,919
Net Income Applicable To Common Shares970,114
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,220,479
Total Other Income/Expenses Net0-23,471
 

Technical Analysis of Bloomage Biotechnology Corp Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bloomage Biotechnology Corp Ltd. The general trend of Bloomage Biotechnology Corp Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bloomage Biotechnology Corp Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bloomage Biotechnology Corp Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 58.50 < 59.34 < 63.98.

The bearish price targets are: 50.22.

Tweet this
Bloomage Biotechnology Corp Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bloomage Biotechnology Corp Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bloomage Biotechnology Corp Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bloomage Biotechnology Corp Ltd. The current macd is -1.47734375.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bloomage Biotechnology Corp Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bloomage Biotechnology Corp Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bloomage Biotechnology Corp Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Bloomage Biotechnology Corp Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBloomage Biotechnology Corp Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bloomage Biotechnology Corp Ltd. The current adx is 21.00.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bloomage Biotechnology Corp Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Bloomage Biotechnology Corp Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bloomage Biotechnology Corp Ltd. The current sar is 62.48.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bloomage Biotechnology Corp Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bloomage Biotechnology Corp Ltd. The current rsi is 32.91. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Bloomage Biotechnology Corp Ltd Daily Relative Strength Index (RSI) ChartBloomage Biotechnology Corp Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bloomage Biotechnology Corp Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bloomage Biotechnology Corp Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Bloomage Biotechnology Corp Ltd Daily Stochastic Oscillator ChartBloomage Biotechnology Corp Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bloomage Biotechnology Corp Ltd. The current cci is -142.35749524.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Bloomage Biotechnology Corp Ltd Daily Commodity Channel Index (CCI) ChartBloomage Biotechnology Corp Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bloomage Biotechnology Corp Ltd. The current cmo is -50.21551009.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bloomage Biotechnology Corp Ltd Daily Chande Momentum Oscillator (CMO) ChartBloomage Biotechnology Corp Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bloomage Biotechnology Corp Ltd. The current willr is -90.92920354.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Bloomage Biotechnology Corp Ltd Daily Williams %R ChartBloomage Biotechnology Corp Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bloomage Biotechnology Corp Ltd.

Bloomage Biotechnology Corp Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bloomage Biotechnology Corp Ltd. The current atr is 1.89186004.

Bloomage Biotechnology Corp Ltd Daily Average True Range (ATR) ChartBloomage Biotechnology Corp Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bloomage Biotechnology Corp Ltd. The current obv is -48,370,497.

Bloomage Biotechnology Corp Ltd Daily On-Balance Volume (OBV) ChartBloomage Biotechnology Corp Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bloomage Biotechnology Corp Ltd. The current mfi is 13.86.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Bloomage Biotechnology Corp Ltd Daily Money Flow Index (MFI) ChartBloomage Biotechnology Corp Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bloomage Biotechnology Corp Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Bloomage Biotechnology Corp Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bloomage Biotechnology Corp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.913
Ma 20Greater thanMa 5060.356
Ma 50Greater thanMa 10061.536
Ma 100Greater thanMa 20065.792
OpenGreater thanClose55.990
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bloomage Biotechnology Corp Ltd with someone you think should read this too:
  • Are you bullish or bearish on Bloomage Biotechnology Corp Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bloomage Biotechnology Corp Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bloomage Biotechnology Corp Ltd

I send you an email if I find something interesting about Bloomage Biotechnology Corp Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Bloomage Biotechnology Corp Ltd.

Receive notifications about Bloomage Biotechnology Corp Ltd in your mailbox!